Italian innovation
in Radiopharmaceuticals.
From industry to clinical practice.
ITELPHARMA contributes to the development of nuclear medicine through research, production and collaboration with the healthcare, industrial and research systems.
Your partner
For the new generation of Radiopharmaceuticals
ITELPHARMA is the company within the ITEL Group dedicated to the production and distribution of radiopharmaceuticals. We work alongside hospitals, research centres and industrial partners to support the evolution of nuclear medicine with innovative, reliable solutions oriented towards clinical practice.
Production, Research and Development
Integrated activities in the radiopharmaceutical field to meet the most advanced clinical and industrial needs.
Quality, Compliance and Reliability
An approach geared to the highest international GMP standards, with full traceability and certified processes.
Integration along the Supply Chain
An active presence across the entire nuclear medicine chain, from research to clinical distribution.
Clinical and Industrial Collaborations
Networks of partnerships with clinical stakeholders, research institutions and the pharmaceutical industry at national and international level.
Come and discover Itelpharma at AIMN
Innovation
We present our research activities and development pipelines in the radiopharmaceutical and theranostic fields.
Production
We showcase our pipeline of radiotracers and share our approach to production in environments governed by high GMP standards.
Collaborations
We explore partnership opportunities with clinical centres, research institutions and industry, and we offer our expertise to meet the needs of the healthcare sector.
Vision
We contribute to the growth, development and advancement of nuclear medicine in Italy.
Our commitment
For the Radiopharmaceuticals supply chain
ITELPHARMA is committed to developing strategic initiatives that strengthen the radiopharmaceutical supply chain, fostering integration between research, production and clinical application.
We work with public and private partners to accelerate innovation and progress in nuclear medicine.
National Consortium
For Innovation in
Nuclear Medicine
ITELPHARMA is an active member of NCIR — the National Consortium for Innovation in Nuclear Medicine — which brings together universities, IRCCS hospitals and research centres to develop the new generation of radiopharmaceuticals in Italy.
A widespread, sustainable infrastructure dedicated to research, development and industrial transfer in the field of nuclear medicine and theranostics.
National Network
Our Production Centres
in Italy
A widespread network of radiopharmaceutical production centres distributed across the country, from North to South.
Each centre operates according to the highest GMP standards, with full traceability and certified processes to support hospitals, IRCCS and research centres.
Molecule Portfolio
An Evolving
Portfolio of Molecules
From oncology diagnostics to theranostic applications, we develop and produce a complete range of radiotracers for modern nuclear medicine.
PSMA-1007, JK-PSMA-7, FDG, Fluorocholine, Flutemetamol, Florbetaben, Fluorodopa, Sodium Fluoride: a continually expanding portfolio in support of clinical practice and research.
Book a meeting
Let’s meet in Bari
Come and visit us during AIMN 2026 to learn more about our activities and meet our team
Brochure
Download our Brochure
Fill in the form to receive the full brochure with our radiopharmaceutical portfolio, production centres and research lines.
Congress venue
How to Get There
Cardinale Agostino Ciasca, 27 — 70124 Bari BA
Contacts
Let’s stay in touch
Our team is available to provide any information about our activities, products and partnership opportunities.